Teligent Announces Conversion Rate Adjustment for its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes Due 2023 and its 4.75% Convertible Senior Notes Due 2023
03 juin 2020 16h15 HE
|
Teligent, Inc.
BUENA, N.J., June 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today conversion...
Teligent Announces One-for-Ten Reverse Stock Split
26 mai 2020 16h30 HE
|
Teligent, Inc.
BUENA, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that as of...
Teligent, Inc. Announces First Quarter 2020 Results
22 mai 2020 07h30 HE
|
Teligent, Inc.
BUENA, N.J., May 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter...
Teligent, Inc. to Hold Conference Call for First Quarter 2020 Results on Friday May 22nd, 2020
19 mai 2020 17h00 HE
|
Teligent, Inc.
BUENA, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on...
TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2019 RESULTS & AMENDMENTS TO EXISTING SECURED CREDIT FACILITIES
08 avr. 2020 07h30 HE
|
Teligent, Inc.
BUENA, N.J., April 08, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth...
Teligent, Inc. to Hold Conference Call for Fourth Quarter and 2019 Full Year Financial Results on Wednesday April 8, 2020
03 avr. 2020 16h05 HE
|
Teligent, Inc.
BUENA, N.J., April 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00 a.m. ET...
Teligent, Inc. Announces Transition in Leadership
05 févr. 2020 08h21 HE
|
Teligent, Inc.
BUENA, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced a transition...
Teligent, Inc. Announces FDA Request for Further Data on Complex Drug
23 déc. 2019 17h12 HE
|
Teligent, Inc.
BUENA, N.J., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its development partner has received a...
Teligent, Inc. to Present at Jefferies Global Healthcare Conference in London on Wednesday November 20, 2019
13 nov. 2019 12h30 HE
|
Teligent, Inc.
BUENA, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies Global Healthcare...
Teligent, Inc. Announces Third Quarter 2019 Results
04 nov. 2019 16h15 HE
|
Teligent, Inc.
BUENA, N.J., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter...